Lansoprazole Capsule, Delayed Release Pellets
Product Images NDC 68788-4141

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68788-4141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Structural Formula (Image 01)

Lansoprazole Structural Formula (Image 01)
Chemical structure of lansoprazole, showing its molecular composition with aromatic rings, nitrogen, oxygen, sulfur atoms, and functional groups as presented in the diagram.*
FDA Label Image

Figure 1. (Image 02)

Figure 1. (Image 02)
A line graph showing the mean severity of day heartburn over time, comparing placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD. The x-axis represents days from the start of treatment up to 60 days, and the y-axis shows mean severity levels from 0 (none) to 3 (severe). Lansoprazole treatments demonstrate a decrease in mean heartburn severity compared to placebo.*
FDA Label Image

Figure 2. (Image 03)

Figure 2. (Image 03)
A line graph showing mean severity of night heartburn over time, comparing placebo and two doses of lansoprazole (15 mg QD and 30 mg QD). The x-axis represents days from start of treatment, and the y-axis indicates mean severity from 0 (none) to 3 (severe).*
FDA Label Image

Lansoprazole Delayed-release Cap Usp 30mg (Image 05)

Lansoprazole Delayed-release Cap Usp 30mg (Image 05)
Label for Lansoprazole Delayed-Release capsules USP 30 mg, generic for Prevacid. The label includes dosage form as delayed-release capsule, manufactured by Mylan Pharmaceuticals Inc., with storage instructions at 20° to 25°C and caution about federal transfer restrictions. Directions for use and a Spanish instruction panel are highlighted in yellow. Lot, expiration, and batch fields are blank placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.